Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
Genitourinary Syndrome of Menopause – Mythbusting for GPs
Dysmenorrhoea in Teens
Winter Virus Preparations
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis